We did an international , multicentre , phase 2b , randomised , double-blind , placebo-controlled , parallel-group , dose-finding clinical trial of tozadenant in levodopa-treated patients with Parkinson 's disease who had motor fluctuations ( at least 25 h off-time per day ) .